Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Reports Second Quarter 2011 Financial Results
Revenues for the Second Quarter Increased to $193 Million
View HTML
Toggle Summary Integra LifeSciences Expands Uni-CP(TM) Compression System Product Range for Mid and Hindfoot Reconstruction
PLAINSBORO, N.J., July 13, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will release a line extension for its Uni-CP™ Compression System. The Uni-CP™ Compression System provides a comprehensive solution for arthrodesis and fracture
View HTML
Toggle Summary Integra LifeSciences to Host Its Second Quarter 2011 Earnings Results Conference Call on July 28, 2011
PLAINSBORO, N.J., July 6, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2011 financial results on Thursday, July 28, 2011. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
View HTML
Toggle Summary Integra Announces Pricing of Convertible Senior Notes
PLAINSBORO, N.J., June 10, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the pricing of $200,000,000 aggregate principal amount of 1.625% convertible senior notes due 2016 (the "notes"). The notes were offered and sold in a private placement solely
View HTML
Toggle Summary Integra Announces Private Placement of Convertible Senior Notes
PLAINSBORO, N.J., June 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has commenced a private offering, subject to market conditions, of $200,000,000 aggregate principal amount of convertible senior notes due 2016.
View HTML
Toggle Summary Integra LifeSciences Lowers Costs and Extends Term of Its $600 Million Credit Facility
PLAINSBORO, N.J., June 8, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has established new terms under its credit facility, including lower pricing and an extended maturity date, with its bank group led by Bank of America, N.A and JPMorgan
View HTML
Toggle Summary Integra LifeSciences to Present at Three Conferences in June
PLAINSBORO, N.J., May 31, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at three conferences in June as follows: On Tuesday, June 7, 2011 - At 10:00 AM ET, Mr. Stuart Essig, CEO of Integra, will present at the Jefferies 2011
View HTML
Toggle Summary Integra LifeSciences Acquires SeaSpine
Integra Spine Doubles Its Distribution Network and Revenue Base in Spinal Hardware Kirt Stephenson Joins Integra as President, U.S. Spine PLAINSBORO, N.J., May 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired SeaSpine, Inc., a
View HTML
Toggle Summary Integra LifeSciences Announces Three-Year Contract With Novation to Provide Luxtec(R) Surgical Headlights
PLAINSBORO, N.J., May 4, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a three-year contract with Novation, the leading healthcare supply contracting company, to provide Luxtec® surgical headlights, light sources and accessories
View HTML
Toggle Summary Integra LifeSciences to Present at the Deutsche Bank Health Care and the Bank of America Merrill Lynch Health Care Conferences
PLAINSBORO, N.J., April 28, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in May as follows: On Monday, May 2, 2011 at 1:30 PM ET., Mr. Brian Larkin, President, Global Spine and Orthobiologics and Head of
View HTML